Latest Breaking News On - Clover biopharmaceutical - Page 2 : comparemela.com
Will China s New COVID-19 Vaccine Work Against the Delta Strain?
thatsmags.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thatsmags.com Daily Mail and Mail on Sunday newspapers.
Clover Biopharma vaccine 79% effective against Delta variant
chinadaily.com.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chinadaily.com.cn Daily Mail and Mail on Sunday newspapers.
PH receives 3 new Covid-19 clinical trial applications
radyonatin.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from radyonatin.com Daily Mail and Mail on Sunday newspapers.
FILE PHOTO
Metro Manila (CNN Philippines, May 16) The country received three new COVID-19 vaccine clinical trial applications, Science and Technology Undersecretary Rowena Guevara said Tuesday.
The vaccine developers that applied to conduct Phase 3 trials were the West China Hospital and Sichuan University, Shenzhen Kangtai Biological Products Co., and Eubiologics Co. Ltd., Guevara said in a briefing.
The undersecretary said evaluation of the applications submitted by the West China Hospital and Sichuan University, as well as Shenzhen Kangtai is underway while Eubiologics is still “completing some requirements.”
Meanwhile, the Department of Science Technology is also waiting the World Health Organization s release of its final protocol and list of COVID-19 shots for its Solidarity vaccine trials in the country. Guevara said WHO is expected to submit the documents “by the end of the month.”
Published May 25, 2021, 2:14 PM
DOST (Manila Bulletin File photo)
Three other vaccine developers are interested in conducting a clinical trial in the Philippines for their respective coronavirus disease (COVID-19) vaccines, the Department of Science and Technology (DOST) said on Tuesday, May 25.
DOST Undersecretary Rowena Guevarra said that the three vaccine developers have already submitted their COVID-19 vaccine clinical trial applications. These are West China Hospital and Sichuan University, Shenzhen Kangtai Biological Products Co., and Eubiologics Co. Ltd.
“Evaluation of the first two new applications are ongoing, while Eubiologics Co. Ltd are still completing some requirements,” said Guevarra in an online forum hosted by the Department of Health (DOH).